These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9923292)

  • 21. Re-engineering the ESRD Program amid Medicare reform.
    Neumann ME
    Nephrol News Issues; 2005 Jan; 19(2):40-1. PubMed ID: 15717573
    [No Abstract]   [Full Text] [Related]  

  • 22. Deaths: final data for 1997.
    Hoyert DL; Kochanek KD; Murphy SL
    Natl Vital Stat Rep; 1999 Jun; 47(19):1-104. PubMed ID: 10410536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
    Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
    J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive summary. United States Renal Data System 1999 Annual Data Report.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S9-S19. PubMed ID: 10430999
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiology and cost of haemodialysis in Jordan.
    Batieha A; Abdallah S; Maghaireh M; Awad Z; Al-Akash N; Batieneh A; Ajlouni KA
    East Mediterr Health J; 2007; 13(3):654-63. PubMed ID: 17687839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive disorder in renal transplantation: an analysis of Medicare claims.
    Dobbels F; Skeans MA; Snyder JJ; Tuomari AV; Maclean JR; Kasiske BL
    Am J Kidney Dis; 2008 May; 51(5):819-28. PubMed ID: 18436093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
    Foley RN; Murray AM; Li S; Herzog CA; McBean AM; Eggers PW; Collins AJ
    J Am Soc Nephrol; 2005 Feb; 16(2):489-95. PubMed ID: 15590763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality in Medicare patients on dialysis for end-stage renal disease (ESRD), 1982-1987.
    Singer RB; Balakrishna SS
    J Insur Med; 1995; 27(1):28-32. PubMed ID: 10169680
    [No Abstract]   [Full Text] [Related]  

  • 30. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S118-31. PubMed ID: 9713414
    [No Abstract]   [Full Text] [Related]  

  • 31. Small improvements seen in patient, staff vaccinations.
    Nephrol News Issues; 2002 Feb; 16(3):18-9, 23-25. PubMed ID: 11859744
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidence and prevalence of ESRD. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S38-49. PubMed ID: 9713406
    [No Abstract]   [Full Text] [Related]  

  • 33. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
    Hattori S; Yosioka K; Honda M; Ito H;
    Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.
    Litovitz TL; Klein-Schwartz W; White S; Cobaugh DJ; Youniss J; Omslaer JC; Drab A; Benson BE
    Am J Emerg Med; 2001 Sep; 19(5):337-95. PubMed ID: 11555795
    [No Abstract]   [Full Text] [Related]  

  • 35. RPA: a more objective voice needed in ESRD rate-setting.
    Levin N
    Nephrol News Issues; 1990 Mar; 4(3):20. PubMed ID: 2320139
    [No Abstract]   [Full Text] [Related]  

  • 36. Unequal access to cadaveric kidney transplantation in California based on insurance status.
    Thamer M; Henderson SC; Ray NF; Rinehart CS; Greer JW; Danovitch GM
    Health Serv Res; 1999 Oct; 34(4):879-900. PubMed ID: 10536975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration.
    Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874
    [No Abstract]   [Full Text] [Related]  

  • 38. Germany leads in ESRD incidence among European countries. Improvements to ERA-EDTA Registry include new studies.
    Nephrol News Issues; 1998 Nov; 12(11):31, 35. PubMed ID: 10026490
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002.
    Demma LJ; Holman RC; McQuiston JH; Krebs JW; Swerdlow DL
    Am J Trop Med Hyg; 2005 Aug; 73(2):400-9. PubMed ID: 16103612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caring for ESRD patients.
    Andriote JM
    Healthplan; 1998; 39(4):33-5. PubMed ID: 10351321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.